SBH
VMD icon

Segall Bryant & Hamill’s Viemed Healthcare VMD Stock Holding History

Segall Bryant & Hamill’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-288,771
Closed -$2.15M – 650
2025
Q4 		$2.15M Sell
288,771
-675
-0.2% -$4.63K 0.03% 426
2025
Q3 		$1.97M Buy
+289,446
New +$1.96M 0.03% 432
2025
Q2 		– Sell
-130,229
Closed -$948K – 638
2025
Q1 		$948K Buy
130,229
+93,242
+252% +$732K 0.01% 504
2024
Q4 		$297K Buy
+36,987
New +$321K ﹤0.01% 569

Other funds holding VMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $266M AUM 40% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return

Segall Bryant & Hamill's VMD Position: Q1 2026 in Review

Segall Bryant & Hamill sold out of Viemed Healthcare (VMD) in Q1 2026, closing a stake of 288,771 shares — an estimated $2.15M sold.

Segall Bryant & Hamill first reported a position in VMD in Q4 2024 and held it in 4 quarters. The position peaked at $2.15M in Q4 2025. 150 funds tracked by Wall St. Rank hold VMD as of Q1 2026.

  • Segall Bryant & Hamill reported no remaining Viemed Healthcare position as of Q1 2026 after selling out during the quarter.
  • Segall Bryant & Hamill sold 288,771 Viemed Healthcare shares in Q1 2026, an estimated $2.15M.
  • Segall Bryant & Hamill first reported a position in Viemed Healthcare in Q4 2024 and held it in 4 quarters.
  • Segall Bryant & Hamill's Viemed Healthcare position peaked at $2.15M in Q4 2025.
  • 150 funds tracked by Wall St. Rank held Viemed Healthcare as of Q1 2026.

Based on Segall Bryant & Hamill's 13F filing for Q1 2026, filed 15 May 2026.